Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 2
1998 3
1999 1
2000 2
2001 5
2002 2
2003 3
2005 1
2010 1
2011 3
2012 8
2013 2
2014 1
2018 1
2019 1
2021 3
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome.
Schwartz GG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Lecorps G, Mahaffey KW, Moryusef A, Pordy R, Quintero K, Roe MT, Sasiela WJ, Tamby JF, Tricoci P, White HD, Zeiher AM; ODYSSEY OUTCOMES Committees and Investigators. Schwartz GG, et al. N Engl J Med. 2018 Nov 29;379(22):2097-2107. doi: 10.1056/NEJMoa1801174. Epub 2018 Nov 7. N Engl J Med. 2018. PMID: 30403574 Free article. Clinical Trial.
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab.
Hagström E, Steg PG, Szarek M, Bhatt DL, Bittner VA, Danchin N, Diaz R, Goodman SG, Harrington RA, Jukema JW, Liberopoulos E, Marx N, McGinniss J, Manvelian G, Pordy R, Scemama M, White HD, Zeiher AM, Schwartz GG; ODYSSEY OUTCOMES Investigators. Hagström E, et al. Circulation. 2022 Aug 30;146(9):657-672. doi: 10.1161/CIRCULATIONAHA.121.057807. Epub 2022 Jun 30. Circulation. 2022. PMID: 35770629 Free PMC article. Clinical Trial.
Rivaroxaban in patients with a recent acute coronary syndrome.
Mega JL, Braunwald E, Wiviott SD, Bassand JP, Bhatt DL, Bode C, Burton P, Cohen M, Cook-Bruns N, Fox KA, Goto S, Murphy SA, Plotnikov AN, Schneider D, Sun X, Verheugt FW, Gibson CM; ATLAS ACS 2–TIMI 51 Investigators. Mega JL, et al. N Engl J Med. 2012 Jan 5;366(1):9-19. doi: 10.1056/NEJMoa1112277. Epub 2011 Nov 13. N Engl J Med. 2012. PMID: 22077192 Free article. Clinical Trial.
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial.
Ray KK, Colhoun HM, Szarek M, Baccara-Dinet M, Bhatt DL, Bittner VA, Budaj AJ, Diaz R, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Loizeau V, Lopes RD, Moryusef A, Murin J, Pordy R, Ristic AD, Roe MT, Tuñón J, White HD, Zeiher AM, Schwartz GG, Steg PG; ODYSSEY OUTCOMES Committees and Investigators. Ray KK, et al. Lancet Diabetes Endocrinol. 2019 Aug;7(8):618-628. doi: 10.1016/S2213-8587(19)30158-5. Epub 2019 Jul 1. Lancet Diabetes Endocrinol. 2019. PMID: 31272931 Free article. Clinical Trial.
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol.
Schwartz GG, Szarek M, Bittner VA, Diaz R, Goodman SG, Jukema JW, Landmesser U, López-Jaramillo P, Manvelian G, Pordy R, Scemama M, Sinnaeve PR, White HD, Gabriel Steg P; ODYSSEY Outcomes Committees and Investigators. Schwartz GG, et al. J Am Coll Cardiol. 2021 Aug 3;78(5):421-433. doi: 10.1016/j.jacc.2021.04.102. J Am Coll Cardiol. 2021. PMID: 34325831 Free PMC article. Clinical Trial.
[Cytomegaloviruses and atherosclerosis].
Popović P, Drasković-Pavlović B, Dincić D, Obradović S. Popović P, et al. Among authors: dincic d. Vojnosanit Pregl. 2002 Jan-Feb;59(1):59-65. doi: 10.2298/vsp0201059p. Vojnosanit Pregl. 2002. PMID: 11928192 Review. Serbian. No abstract available.
Arterial hypertension in the elderly.
Ivanović B, Dincić D, Tadić M, Simić D. Ivanović B, et al. Among authors: dincic d. Vojnosanit Pregl. 2011 Sep;68(9):779-85. doi: 10.2298/vsp1109779i. Vojnosanit Pregl. 2011. PMID: 22046884 Review. No abstract available.
The association of ACE I/D gene polymorphism with severe carotid atherosclerosis in patients undergoing carotid endarterectomy.
Kolaković A, Zivković M, Radak D, Djurić T, Koncar I, Davidović L, Dincić D, Alavantić D, Stanković A. Kolaković A, et al. Among authors: dincic d. J Renin Angiotensin Aldosterone Syst. 2012 Mar;13(1):141-7. doi: 10.1177/1470320311423271. Epub 2011 Oct 7. J Renin Angiotensin Aldosterone Syst. 2012. PMID: 21984781 Free article.
Heart rate--predictor of cardiovascular risk.
Ivanović BA, Tadić M, Dincić D. Ivanović BA, et al. Among authors: dincic d. Vojnosanit Pregl. 2012 Sep;69(9):799-802. Vojnosanit Pregl. 2012. PMID: 23050406 Review. No abstract available.
[Hemostasis and atherosclerosis].
Obradović S, Jovicić A, Djordjević D, Gligić B, Dincić D, Stamatović D. Obradović S, et al. Among authors: dincic d. Vojnosanit Pregl. 2000 Mar-Apr;57(2):209-16. Vojnosanit Pregl. 2000. PMID: 10934935 Review. Serbian. No abstract available.
37 results